<p>Hound Partners LLC 在最近向证券交易委员会（SEC）提交的 13F 表格中表示，在第二季度将其在 HCA Healthcare, Inc.（纽约证券交易所代码：HCA - 免费报告）的持仓减少了 10.0%。该公司在季度内出售了 3,535 股后，持有 31,832 股 HCA Healthcare 的股票。HCA Healthcare 占 Hound Partners LLC 投资组合的约 1.6%，是其第 17 大持仓。Hound Partners LLC 在 HCA Healthcare 的持股在最近的报告期末价值为 12,195,000 美元。</p>
<ul>
<li>MarketBeat 周报 – 07/28 - 08/01</li>
</ul>
<p>其他几家对冲基金和机构投资者也对该公司的股份进行了增持或减持。挪威银行在第二季度购买了 HCA Healthcare 的新股份，价值约为 1,152,408,000 美元。Price T Rowe Associates Inc. MD 在第一季度将其在 HCA Healthcare 的持股增加了 83.4%。Price T Rowe Associates Inc. MD 目前持有 2,399,372 股该公司的股票，价值 829,104,000 美元，此前在上个季度增持了 1,091,416 股。Viking Global Investors LP 在第二季度将其在 HCA Healthcare 的持仓增加了 58.5%。Viking Global Investors LP 目前持有 1,872,133 股该公司的股票，价值 717,214,000 美元，此前在上个季度购买了 690,773 股。Abdiel Capital Advisors LP 在第一季度购买了 HCA Healthcare 的新股份，价值约为 164,835,000 美元。最后，VIRGINIA RETIREMENT SYSTEMS ET Al 在第二季度购买了 HCA Healthcare 的新股份，价值约为 109,337,000 美元。目前，62.73% 的股票由机构投资者持有。</p>
<p>获取 <strong>HCA Healthcare</strong> 警报：</p>
<h2>华尔街分析师预测增长</h2>
<p>几位股票分析师对 HCA 股票发表了评论。瑞银集团在 10 月 27 日的研究报告中将 HCA Healthcare 的目标价从 495.00 美元上调至 525.00 美元，并给予该公司 “买入” 评级。Zacks Research 在 11 月 27 日的报告中将 HCA Healthcare 的评级从 “强力买入” 下调至 “持有”。Oppenheimer 在 10 月 27 日的研究报告中将 HCA Healthcare 的目标价从 400.00 美元上调至 500.00 美元，并给予该公司 “跑赢大盘” 评级。Weiss Ratings 在周一的研究报告中重申了对 HCA Healthcare 的 “买入（b）” 评级。最后，高盛集团在 10 月 27 日的研究报告中将 HCA Healthcare 的目标价从 470.00 美元上调至 520.00 美元，并给予该股票 “买入” 评级。十四位研究分析师对该股票给予了买入评级，十位分析师给予了持有评级。根据 MarketBeat 的数据，该公司的共识评级为 “适度买入”，共识目标价为 475.95 美元。</p>
<ul>
<li>HCA Healthcare 能否振兴市场最弱的行业？</li>
</ul>
<p><strong>查看我们关于 HCA Healthcare 的最新研究报告</strong></p>
<h2>内部买卖情况</h2>
<p>在其他消息中，执行副总裁 Michael R. Mcalevey 于 11 月 5 日星期三出售了 3,892 股该公司的股票。股票以平均价格 473.79 美元出售，总交易额为 1,843,990.68 美元。出售后，该执行副总裁持有 3,487 股该公司的股票，价值 1,652,105.73 美元。此交易代表其持仓减少了 52.74%。该出售在向证券交易委员会提交的文件中披露，文件可通过此链接获取。公司内部人士持有该公司 1.30% 的股票。</p>
<h2>HCA Healthcare 股票表现</h2>
<ul>
<li>综合医疗股票能否在公开市场上成功？</li>
</ul>
<p>HCA Healthcare 股票在周五开盘价为 484.67 美元。该股票的市值为 1,106 亿美元，市盈率为 18.73，市盈增长比率为 1.42，贝塔值为 1.36。该股票的 50 日移动平均线为 465.59 美元，200 日移动平均线为 413.62 美元。HCA Healthcare, Inc. 的一年最低价为 289.98 美元，一年最高价为 520.00 美元。</p>
<p>HCA Healthcare（纽约证券交易所代码：HCA - 获取免费报告）最近于 10 月 24 日发布了季度收益结果。该公司报告本季度每股收益为 6.96 美元，超出市场共识预期的 5.64 美元，超出幅度为 1.32 美元。HCA Healthcare 的净利润率为 8.53%，股本回报率为负 792.25%。该公司本季度的收入为 191.6 亿美元，而市场共识预期为 185.5 亿美元。在去年同期，该公司每股收益为 4.90 美元。HCA Healthcare 的季度收入同比增长 9.6%。HCA Healthcare 已设定 2025 财年的每股收益指导为 27.000-28.000。整体来看，卖方分析师预测 HCA Healthcare, Inc. 本财年将发布 24.98 美元的每股收益。</p>
<h2>HCA Healthcare 分红公告</h2>
<p>该公司最近还宣布了一项季度分红，将于 12 月 29 日星期一支付。12 月 15 日星期一的登记投资者将获得每股 0.72 美元的分红。这代表每年 2.88 美元的分红，收益率为 0.6%。该分红的除息日为 12 月 15 日星期一。HCA Healthcare 的分红支付比率（DPR）为 11.13%。</p>
<h2>HCA Healthcare 公司简介</h2>
<p>（免费报告）</p>
<p>HCA Healthcare, Inc. 通过其子公司在美国拥有和运营医院及相关医疗实体。它经营提供医疗和外科服务的综合医院和急性护理医院，包括住院护理、重症监护、心脏护理、诊断和急救服务；以及门诊服务，如门诊手术、实验室、放射学、呼吸治疗、心脏病学和物理治疗。</p>
<h2>特色文章</h2>
<ul>
<li>我们更看好的五只股票，胜过 HCA Healthcare</li>
<li>保护您的投资组合免受冠状病毒影响的三只股票</li>
<li>MarketBeat 周报 – 12/8 - 12/12</li>
<li>投资者必须了解的场外交易（OTC）股票</li>
<li>Synopsys 看到乐观转变，因 Ansys 整合推动增长</li>
<li>揭示 VWAP 的力量：交易者的关键指标</li>
<li>你能给自己最好的节日礼物是什么？Costco 股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 $1,000 在 HCA Healthcare 吗？</h2>
<p>在考虑 HCA Healthcare 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前... 而 HCA Healthcare 并不在名单上。</p>
<p>虽然 HCA Healthcare 目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

HCA控股

<p>Hound Partners LLC 在第二季度减少了对 HCA Healthcare 的持股比例，出售了 3,535 股，持股比例下降了 10%。HCA 现在占 Hound 投资组合的 1.6%。机构投资者持有 HCA 股票的 62.73%。分析师对 HCA 的评级一致为 “适度买入”，目标价格为 475.95 美元。HCA 第三季度的收益超出预期，收入同比增长 9.6%。该股票开盘价为 484.67 美元，市值为 1,106 亿美元</p>

<p>Hound Partners LLC reduced its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 10.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,832 shares of the company's stock after selling 3,535 shares during the quarter. HCA Healthcare makes up about 1.6% of Hound Partners LLC's investment portfolio, making the stock its 17th largest holding. Hound Partners LLC's holdings in HCA Healthcare were worth $12,195,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>Hound Partners LLC 在最近向证券交易委员会（SEC）提交的 13F 表格中表示，在第二季度将其在 HCA Healthcare, Inc.（纽约证券交易所代码：HCA - 免费报告）的持仓减少了 10.0%。该公司在季度内出售了 3,535 股后，持有 31,832 股 HCA Healthcare 的股票。HCA Healthcare 占 Hound Partners LLC 投资组合的约 1.6%，是其第 17 大持仓。Hound Partners LLC 在 HCA Healthcare 的持股在最近的报告期末价值为 12,195,000 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 07/28 - 08/01</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周报 – 07/28 - 08/01</li>
</ul>
</div><p>Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Norges Bank bought a new stake in shares of HCA Healthcare during the second quarter valued at approximately $1,152,408,000. Price T Rowe Associates Inc. MD increased its holdings in HCA Healthcare by 83.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company's stock valued at $829,104,000 after acquiring an additional 1,091,416 shares during the last quarter. Viking Global Investors LP grew its position in shares of HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company's stock valued at $717,214,000 after purchasing an additional 690,773 shares in the last quarter. Abdiel Capital Advisors LP bought a new position in HCA Healthcare during the first quarter valued at approximately $164,835,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of HCA Healthcare during the 2nd quarter worth approximately $109,337,000. 62.73% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他几家对冲基金和机构投资者也对该公司的股份进行了增持或减持。挪威银行在第二季度购买了 HCA Healthcare 的新股份，价值约为 1,152,408,000 美元。Price T Rowe Associates Inc. MD 在第一季度将其在 HCA Healthcare 的持股增加了 83.4%。Price T Rowe Associates Inc. MD 目前持有 2,399,372 股该公司的股票，价值 829,104,000 美元，此前在上个季度增持了 1,091,416 股。Viking Global Investors LP 在第二季度将其在 HCA Healthcare 的持仓增加了 58.5%。Viking Global Investors LP 目前持有 1,872,133 股该公司的股票，价值 717,214,000 美元，此前在上个季度购买了 690,773 股。Abdiel Capital Advisors LP 在第一季度购买了 HCA Healthcare 的新股份，价值约为 164,835,000 美元。最后，VIRGINIA RETIREMENT SYSTEMS ET Al 在第二季度购买了 HCA Healthcare 的新股份，价值约为 109,337,000 美元。目前，62.73% 的股票由机构投资者持有。</p>
</div><p>Get <strong>HCA Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>HCA Healthcare</strong> 警报：</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>Several equities analysts have commented on HCA shares. UBS Group increased their price objective on shares of HCA Healthcare from $495.00 to $525.00 and gave the company a &#34;buy&#34; rating in a research report on Monday, October 27th. Zacks Research cut HCA Healthcare from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a report on Thursday, November 27th. Oppenheimer boosted their price objective on shares of HCA Healthcare from $400.00 to $500.00 and gave the company an &#34;outperform&#34; rating in a research report on Monday, October 27th. Weiss Ratings reiterated a &#34;buy (b)&#34; rating on shares of HCA Healthcare in a research report on Monday. Finally, The Goldman Sachs Group upped their target price on shares of HCA Healthcare from $470.00 to $520.00 and gave the stock a &#34;buy&#34; rating in a research note on Monday, October 27th. Fourteen research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $475.95.</p>
<div class="lb-trans"><p>几位股票分析师对 HCA 股票发表了评论。瑞银集团在 10 月 27 日的研究报告中将 HCA Healthcare 的目标价从 495.00 美元上调至 525.00 美元，并给予该公司 “买入” 评级。Zacks Research 在 11 月 27 日的报告中将 HCA Healthcare 的评级从 “强力买入” 下调至 “持有”。Oppenheimer 在 10 月 27 日的研究报告中将 HCA Healthcare 的目标价从 400.00 美元上调至 500.00 美元，并给予该公司 “跑赢大盘” 评级。Weiss Ratings 在周一的研究报告中重申了对 HCA Healthcare 的 “买入（b）” 评级。最后，高盛集团在 10 月 27 日的研究报告中将 HCA Healthcare 的目标价从 470.00 美元上调至 520.00 美元，并给予该股票 “买入” 评级。十四位研究分析师对该股票给予了买入评级，十位分析师给予了持有评级。根据 MarketBeat 的数据，该公司的共识评级为 “适度买入”，共识目标价为 475.95 美元。</p>
</div><ul>
<li>Can HCA Healthcare Revive the Market’s Weakest Sector?</li>
</ul>
<div class="lb-trans"><ul>
<li>HCA Healthcare 能否振兴市场最弱的行业？</li>
</ul>
</div><p><strong>View Our Latest Research Report on HCA Healthcare</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 HCA Healthcare 的最新研究报告</strong></p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部买卖情况</h2>
</div><p>In other news, EVP Michael R. Mcalevey sold 3,892 shares of the firm's stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the sale, the executive vice president owned 3,487 shares of the company's stock, valued at $1,652,105.73. This trade represents a 52.74% decrease in their position. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available through this link. Corporate insiders own 1.30% of the company's stock.</p>
<div class="lb-trans"><p>在其他消息中，执行副总裁 Michael R. Mcalevey 于 11 月 5 日星期三出售了 3,892 股该公司的股票。股票以平均价格 473.79 美元出售，总交易额为 1,843,990.68 美元。出售后，该执行副总裁持有 3,487 股该公司的股票，价值 1,652,105.73 美元。此交易代表其持仓减少了 52.74%。该出售在向证券交易委员会提交的文件中披露，文件可通过此链接获取。公司内部人士持有该公司 1.30% 的股票。</p>
</div><h2>HCA Healthcare Stock Performance</h2>
<div class="lb-trans"><h2>HCA Healthcare 股票表现</h2>
</div><ul>
<li>Can Integrated Healthcare Stocks Succeed in Public Markets?</li>
</ul>
<div class="lb-trans"><ul>
<li>综合医疗股票能否在公开市场上成功？</li>
</ul>
</div><p>HCA Healthcare stock opened at $484.67 on Friday. The stock has a market cap of $110.60 billion, a PE ratio of 18.73, a price-to-earnings-growth ratio of 1.42 and a beta of 1.36. The stock has a 50-day moving average of $465.59 and a two-hundred day moving average of $413.62. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $520.00.</p>
<div class="lb-trans"><p>HCA Healthcare 股票在周五开盘价为 484.67 美元。该股票的市值为 1,106 亿美元，市盈率为 18.73，市盈增长比率为 1.42，贝塔值为 1.36。该股票的 50 日移动平均线为 465.59 美元，200 日移动平均线为 413.62 美元。HCA Healthcare, Inc. 的一年最低价为 289.98 美元，一年最高价为 520.00 美元。</p>
</div><p>HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping the consensus estimate of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. During the same quarter in the prior year, the company earned $4.90 EPS. HCA Healthcare's quarterly revenue was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>HCA Healthcare（纽约证券交易所代码：HCA - 获取免费报告）最近于 10 月 24 日发布了季度收益结果。该公司报告本季度每股收益为 6.96 美元，超出市场共识预期的 5.64 美元，超出幅度为 1.32 美元。HCA Healthcare 的净利润率为 8.53%，股本回报率为负 792.25%。该公司本季度的收入为 191.6 亿美元，而市场共识预期为 185.5 亿美元。在去年同期，该公司每股收益为 4.90 美元。HCA Healthcare 的季度收入同比增长 9.6%。HCA Healthcare 已设定 2025 财年的每股收益指导为 27.000-28.000。整体来看，卖方分析师预测 HCA Healthcare, Inc. 本财年将发布 24.98 美元的每股收益。</p>
</div><h2>HCA Healthcare Dividend Announcement</h2>
<div class="lb-trans"><h2>HCA Healthcare 分红公告</h2>
</div><p>The business also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare's dividend payout ratio (DPR) is 11.13%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度分红，将于 12 月 29 日星期一支付。12 月 15 日星期一的登记投资者将获得每股 0.72 美元的分红。这代表每年 2.88 美元的分红，收益率为 0.6%。该分红的除息日为 12 月 15 日星期一。HCA Healthcare 的分红支付比率（DPR）为 11.13%。</p>
</div><h2>HCA Healthcare Profile</h2>
<div class="lb-trans"><h2>HCA Healthcare 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.</p>
<div class="lb-trans"><p>HCA Healthcare, Inc. 通过其子公司在美国拥有和运营医院及相关医疗实体。它经营提供医疗和外科服务的综合医院和急性护理医院，包括住院护理、重症监护、心脏护理、诊断和急救服务；以及门诊服务，如门诊手术、实验室、放射学、呼吸治疗、心脏病学和物理治疗。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>特色文章</h2>
</div><ul>
<li>Five stocks we like better than HCA Healthcare</li>
<li>3 Stocks to Protect Your Portfolio from the Coronavirus Contagion</li>
<li>MarketBeat Week in Review – 12/8 - 12/12</li>
<li>What Investors Must Know About Over-the-Counter (OTC) Stocks</li>
<li>Synopsys Sees Bullish Shift as Ansys Integration Drives Growth</li>
<li>Unveiling The Power Of VWAP: A Key Indicator For Traders</li>
<li>The Best Holiday Present You Can Give Yourself? Costco Stock</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过 HCA Healthcare</li>
<li>保护您的投资组合免受冠状病毒影响的三只股票</li>
<li>MarketBeat 周报 – 12/8 - 12/12</li>
<li>投资者必须了解的场外交易（OTC）股票</li>
<li>Synopsys 看到乐观转变，因 Ansys 整合推动增长</li>
<li>揭示 VWAP 的力量：交易者的关键指标</li>
<li>你能给自己最好的节日礼物是什么？Costco 股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=HCA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in HCA Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 $1,000 在 HCA Healthcare 吗？</h2>
</div><p>Before you consider HCA Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 HCA Healthcare 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前... 而 HCA Healthcare 并不在名单上。</p>
</div><p>While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 HCA Healthcare 目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Hound Partners LLC 出售了 3,535 股 HCA 控股公司的股票 $HCA